Form 4 for VNRX VOLITIONRX LTD
Accepted 2022-06-24 00:00:00 ET · period of report 2022-06-23 · accession 0001477932-22-004655 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-24 | 2022-06-23 | VNRX | Rootsaert Rodney Gerard | Sec | A - Grant | $0.00 | +13.1K | 40.5K | +48% | $0 |
| D | 2022-06-24 | 2022-06-23 | VNRX | Rootsaert Rodney Gerard | Sec | A - Grant | $0.00 | +24.1K | 37.0K | +186% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-23 | A | A | 13,068 | $0.00 | 40,502 | D | — | — | (F1) On August 3, 2021, the reporting person was awarded 20,104 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 13,068 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 6,534 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in April 2022, the rights with respect to the remaining 7,036 restricted stock units subject to the award previously vested and remain subject to time-based vesting. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-23 | A | A | 24,083 | $0.00 | 37,050 | D | $3.40 · — to 2031-08-03 | 24,083 Common Stock | (F3) On August 3, 2021, the reporting person was granted an option to purchase 37,050 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 24,083 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 12,042 shares and 12,041 shares on each of August 3, 2022 and August 3, 2023, respectively. As reported in April 2022, the rights with respect to the remaining 12,967 shares subject to the award previously vested and remain subject to time-based vesting. |